Close Menu

HIV

Scientists from PATH and the US Centers for Disease Control will collaborate under a three-year grant from the National Institutes of Health to further develop and test a non-instrumented DNA amplification kit for diagnosing diseases in resource-poor areas of the world, according

By Adam Bonislawski
Virginia Tech scientists have developed an algorithm that uses protein interaction data to make predictions about the function of individual molecules.

This story has been updated to correct a statement regarding H1 revenues from NextGen's biomarker qualification panels.

By Ben Butkus
Clinical diagnostic test maker Iquum this week received US Food and Drug Administration clearance for its Liat Influenza A/B assay and fully automated and integrated Liat Analyzer.

The NextGen Group said this week its US subsidiary NextGen Sciences has signed a deal with the University of Nebraska for use of its csfdiscovery43 biomarker discovery assay.

By Monica Heger
This story, originally published Aug. 16, has been updated to clarify information about the performance of the company's tests.

A nucleic acid test marketed by Novartis Diagnostics and manufactured by Gen-Probe to screen individual blood donations for HIV and hepatitis have significantly increased the safety of the South African blood supply, according to recently presented data.

Pages

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.